
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🕒 4 days ago
Vice President of Sales at Kyverna Therapeutics leading U.S. commercial sales for CAR-T therapies. Responsible for building high-performing sales organization and executing go-to-market strategy.
🕒 June 25
Medical Science Liaison focusing on CAR-T therapies for autoimmune diseases at Kyverna Therapeutics. Engaging with healthcare professionals and supporting clinical research collaborations within the territory.
🕒 June 16
SVP of Manufacturing and Supply at Kyverna engineering cell therapies for autoimmune diseases. Leading manufacturing and supply chain functions to meet significant medical needs.
🇺🇸 United States – Remote
💵 $365k - $400k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
👔 Vice President
🕒 June 12
Director responsible for commercial channel infrastructure for CAR T therapy delivery at Kyverna Therapeutics. Leading distribution strategies and collaborating with multiple departments to ensure compliance and effectiveness.
🇺🇸 United States – Remote
💵 $190k - $230k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🔴 Lead
⚙️ Operations
🕒 June 8
Vice President, Lifecycle Leader at Kyverna Therapeutics driving clinical and regulatory strategies. Leading the company's therapeutic programs toward regulatory approval and commercialization.
🇺🇸 United States – Remote
💵 $300k - $340k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
👔 Vice President
🕒 June 5
Head of Field Market Access at Kyverna Therapeutics, driving access and coverage for cellular therapies. Leading market access team in payer engagement and strategic account management.
🇺🇸 United States – Remote
💵 $275k - $295k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
👔 Director
🕒 May 18
Senior Director, Clinical Scientist at Kyverna Therapeutics developing cell therapies for autoimmune diseases. Overseeing clinical research and leading scientific execution of clinical programs for Multiple Sclerosis.
🇺🇸 United States – Remote
💵 $260k - $290k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
🧪 Clinical Research
🕒 May 18
Medical Director/Sr. Medical Director overseeing CAR T-cell therapy clinical trials for autoimmune diseases. Collaborating with teams on design, execution, and regulatory compliance in clinical development.
🇺🇸 United States – Remote
💵 $330k - $370k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
🕒 May 1
Senior Clinical Research Scientist at Kyverna advancing cell therapies for autoimmune diseases. Driving high-quality study execution and optimizing clinical processes in a fast-paced environment.
🇺🇸 United States – Remote
💵 $140k - $160k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
🧪 Clinical Research
🕒 April 17
Executive Director providing strategic regulatory leadership across Kyverna's cell therapy portfolio. Focus on commercial readiness, labeling strategy, and health authority engagement.
🇺🇸 United States – Remote
💵 $270k - $300k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🔴 Lead
🚔 Compliance
🕒 March 7
Driving external growth strategy through business development at Kyverna Therapeutics. Leading partnerships, licensing transactions, and alliance management for autoimmune therapies.
🏄 California – Remote
💵 $260k - $290k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
💰 Business Development (BDR)